These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3246085)

  • 21. Pseudoporphyria induced by propionic acid derivatives.
    Al-Khenaizan S; Schechter JF; Sasseville D
    J Cutan Med Surg; 1999 Jan; 3(3):162-6. PubMed ID: 10082597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudoporphyria and sunbeds.
    Stenberg A
    Acta Derm Venereol; 1990; 70(4):354-6. PubMed ID: 1977267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudoporphyria from nonsteroidal anti-inflammatory drugs.
    Nicholls D
    N Z Med J; 1987 Jul; 100(827):427-8. PubMed ID: 3452072
    [No Abstract]   [Full Text] [Related]  

  • 24. Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.
    De Silva B; Banney L; Uttley W; Luqmani R; Schofield O
    Pediatr Dermatol; 2000; 17(6):480-3. PubMed ID: 11123786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudoporphyria secondary to non-steroidal anti-inflammatory drugs.
    Bryant P; Lachman P
    Arch Dis Child; 2003 Nov; 88(11):961. PubMed ID: 14612354
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pseudoporphyria].
    Petersen CS; Thomsen K
    Ugeskr Laeger; 1992 Jun; 154(24):1713-5. PubMed ID: 1632009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudoporphyria and propionic acid non-steroidal anti-inflammatory drugs.
    Meggitt SJ; Farr PM
    Br J Dermatol; 1999 Sep; 141(3):591-2. PubMed ID: 10583088
    [No Abstract]   [Full Text] [Related]  

  • 28. Early onset pauciarticular arthritis is the major risk factor for naproxen-induced pseudoporphyria in juvenile idiopathic arthritis.
    Schäd SG; Kraus A; Haubitz I; Trcka J; Hamm H; Girschick HJ
    Arthritis Res Ther; 2007; 9(1):R10. PubMed ID: 17266758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Flutamide and pseudoporphyria].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 1999 Apr; 126(4):374. PubMed ID: 10421946
    [No Abstract]   [Full Text] [Related]  

  • 30. Pseudoporphyria due to dyazide in a patient with vitiligo.
    Motley RJ
    BMJ; 1990 Jun; 300(6737):1468. PubMed ID: 2379016
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased risk of facial scars in children taking nonsteroidal antiinflammatory drugs.
    Wallace CA; Farrow D; Sherry DD
    J Pediatr; 1994 Nov; 125(5 Pt 1):819-22. PubMed ID: 7965441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imatinib-induced pseudoporphyria.
    Timmer-de Mik L; Kardaun SH; Kramer MH; Hayes DP; Bousema MT
    Clin Exp Dermatol; 2009 Aug; 34(6):705-7. PubMed ID: 19077095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudoporphyria induced by voriconazole.
    Sharp MT; Horn TD
    J Am Acad Dermatol; 2005 Aug; 53(2):341-5. PubMed ID: 16021136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent blisters on the hands and face.
    McNail S; Parker SR
    Arch Dermatol; 2002 Dec; 138(12):1607-12. PubMed ID: 12472353
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lupus erythematosus and porphyria in patients with vitiligo].
    Abdusametova ShR; Kolmakova AN
    Vestn Dermatol Venerol; 1977 Jul; (7):58-9. PubMed ID: 899239
    [No Abstract]   [Full Text] [Related]  

  • 36. Diclofenac-induced pseudoporphyria; an under-recognized condition?
    Turnbull N; Callan M; Staughton RC
    Clin Exp Dermatol; 2014 Apr; 39(3):348-50. PubMed ID: 24635077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term followup of naproxen-induced pseudoporphyria in juvenile rheumatoid arthritis.
    Mehta S; Lang B
    Arthritis Rheum; 1999 Oct; 42(10):2252-4. PubMed ID: 10524703
    [No Abstract]   [Full Text] [Related]  

  • 38. Nabumetone-associated pseudoporphyria.
    Antony F; Layton AM
    Br J Dermatol; 2000 May; 142(5):1067-9. PubMed ID: 10809892
    [No Abstract]   [Full Text] [Related]  

  • 39. [Common physiopathologic manifestations of diseases associated with vitiligo].
    Roder H
    Dermatol Monatsschr; 1969; 155(6):377-81. PubMed ID: 5386748
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyclosporine-induced pseudoporphyria.
    Hivnor C; Nosauri C; James W; Poh-Fitzpatrick M
    Arch Dermatol; 2003 Oct; 139(10):1373-4. PubMed ID: 14568849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.